` OPTI (OptiBiotix Health PLC) vs FTSE All Share Index Comparison - Alpha Spread

OPTI
vs
F
FTSE All Share Index

Over the past 12 months, OPTI has outperformed FTSE All Share Index, delivering a return of -66% compared to the FTSE All Share Index's 0% growth.

Stocks Performance
OPTI vs FTSE All Share Index

Loading
OPTI
FTSE All Share Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
OPTI vs FTSE All Share Index

Performance Gap Between OPTI and ASX
HIDDEN
Show

Performance By Year
OPTI vs FTSE All Share Index

Loading
OPTI
FTSE All Share Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
OptiBiotix Health PLC vs Peers

FTSE All Share Index
OPTI
RYI
GLDD
AVGR
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

OptiBiotix Health PLC
Glance View

Market Cap
6.5m GBX
Industry
Biotechnology

Optibiotix Health Plc is engaged in the research and development of compounds that modify the human microbiome. is a life sciences company. The firm is primarily engaged in identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry segment. The Company’s technology platforms include OptiBiome, OptiScreen and OptiBiotic. Its OptiBiome technology platform that screens identifies and/or develops microbiome modulators, which can be used in formulations to prevent, manage and a range of chronic lifestyle diseases. The Company’s OptiScreen pharmaceutical screening platform to identify microbial metabolic pathways that interact with human pathways to improve health. Its OptiBiotic platform generates oligosaccharides and screens them for their ability to modulate specific microbial genera or species and their microbial end products (short chain fatty acids, such as acetate, propionate, butyrate) and physical properties (sweetness). Its products include SlimBiome, SweetBiotix, CholBiome, SlimBiome Medical and WellBiome.

OPTI Intrinsic Value
HIDDEN
Show
Back to Top